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Amphiphilic block copolymers contain- 
ing poly(dimethylsiloxane), poly(ethy1ene 
oxide), as well as heparin-coated glass 
beads and tubes were evaluated for the 
amounts and activities of surface-immobi- 
lized heparin. Because the amphiphilic co- 
polymer system is thermodynanmcally 
predicted to demonstrate low-energy 
phase enrichment on the surfaces of air- 
cast films, studies were also undertaken to 
understand the in vitro results. Solvent- 
cast copolymer films have a heterogeneous 
microphase-separated structure according 
to transmission electron micrographs. Wil- 
helmy plate contact angle analysis indi- 
cates significant surface restructuring 
occurs upon hydration. Attenuated total 
reflectance infrared spectroscopy studies 
of the desiccated and hydrated films at 
two different sampling depths show com- 
positional heterogeneity as a function of 
depth, as well as near surface restructur- 
ing allowing surface enrichment of the 
high-energy segments following contact 
with water. Significant concentrations of 
heparin are detected on the surface of 
these coatings by toluidine blue assays. In 
addition, a portion of the surface-bound 
heparin maintains its original bioactivity 
as determined by recalcification times, 
thrombin times, and Factor Xa assays. 
These substrates were also tested for 
platelet adhesion and activation reactions 
in vitro using polymer-coated beads in 
rabbit platelet-rich plasma. Heparinized 
polymers promoted low levels of platelet 
adhesion and serotonin release. Surface 
concentrations of heparin from bioactivity 
assays were then correlated with platelet 
adhesion and the extent of platelet release 
to assess the efficacy of this heparin-im- 
mobilized copolymer as a blood-compat- 
ible material or coating. 
INTRODUCTION 
Since the major problems with blood-contacting biomaterials occur at the 
interface between blood and the implanted material, the research presently 
undertaken to improve the performance of these biomaterials has focused 
on the characterization of the implant interface and prevention of surface- 
induced thrombosis. One approach for improving blood compatibility of bio- 
*Present address: Oregon Graduate Institute, Beaverton, OR 97006-1999. 
+To whom correspondence should be sent. 
Journal of Biomedical Materials Research, Vol. 24, 403-431 (1990) 
0 1990 John Wiley & Sons, Inc. CCC 0021-9304/90/040403-29$04.00 
404 GRAINGER ET AL. 
materials has been to immobilize anticoagulants, particularly heparin, at 
interfaces. Most attempts have followed one of the following 
1) ionic binding of heparin onto the material surfaces, 2) covalent attach- 
ment of heparin onto or into the materials, or 3) chemical modification of 
the material surfaces to confer heparin-like properties. 
Optimum efficacy from these approaches might be provided by heparin- 
ized materials which: 1) provide sustained, controlled release of heparin from 
the material surfaces at efficacious concentrations or maintain an effective 
surface-immobilized microenvironment to prevent surface-induced throm- 
bosis, and 2) preserve the bioactivity of the bound, released, or immobilized 
heparin, particularly its ability to bind antithrombin 111. 
Recently, it has been shown that immobilized heparin’s bioactivity is very 
sensitive to its mode of attachment.%’ Efforts have been made to avoid utiliz- 
ing certain functional groups on heparin and to use spacer chains to immo- 
bilize the heparin away from the surface into a more ”bulk-like” environment. 
Our most recent work to immobilize heparin onto materials has been the 
synthesis and characterization of amphiphilic block copolymers containing 
a hydrophobic block of poly(dimethylsi1oxane) (PDMS), a hydrophilic block 
of poly(ethy1ene oxide) (PEO), and a heparin moiety.6 The goal of this strat- 
egy is to investigate both the effect of the hydrophilic-hydrophobic balance 
of the block copolymers and covalently bound heparin on interfacial re- 
sponses with blood, Of particular interest are the phase-enrichment phe- 
nomena which, as thermodynamically driven processes, occur on surfaces 
of segmented and block copolymers in response to external  environment^.^-^ 
Surface characterization using contact angle, electron microscopy, and 
attenuated total reflectance infrared spectroscopy (ATWFTIR) under both 
ambient and hydrated conditions was undertaken in order to provide a 
quantitative basis for explaining the interfacial phenomena observed for 
PDMS-PEO-heparin triblock copolymers in vitro. This paper presents the re- 
sults of the surface characterization methods, various efforts to quantify the 
amounts and bioactivities of heparin on the surfaces of these copolymers, 
and an assessment of their utility as new blood-compatible materials. 
EXPERIMENTAL 
Materials 
Block copolymers of PDMS-PEO-heparin and PDMS-PEO were synthesized 
and characterized as described previously6 and stored frozen in moisture- 
sealed amber bottles. The synthesis, as shown in Figure 1, involved cova- 
lent coupling of semitelechelic amino-PDMS via a diisocyanate to diamino 
terminated PEO in solution. Heparin was then coupled to PDMS-PEO by 
either EDC-activation of carboxylic groups or reductive amination using 
NaCNBH,. 
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Figure 1. Synthetic outline for PDMS-PEO-heparin. 
PDMS coatings for control samples were made from RTV 731 Silastic ad- 
hesive (Dow Corning, Midland, MI) or Silastic RTV adhesive (General Elec- 
tric, Waterford, NY). 
Heparin: Commercial heparin (Diosynth, Chicago, IL) with an activity of 
176.4 IU/mg as determined by the manufacturer was used as supplied for 
heparin standards. 
0-toluidine blue: A toluidine blue solution (0.0015%) was obtained by 
adding solid o-toluidine blue (15 mg/L, Sigma Chemical, St. Louis, MO) 
and 2.0 g NaCl to 1 liter HC1 (0.01 N). 
Rabbit brain cephalin (1 lyophilized vial, Sigma Chemical, Taufkirchen, 
FRG) was diluted according to supplied instructions with 30 mL of an aque- 
ous NaCl solution (0.85%) and frozen in 3-mL aliquots until used. 
Thrombin (Thrombinair, Armour Pharmaceutical Co., Kankakee, IL, 
1000 U/vial) was diluted with sterile water to 10 U/mL and stored frozen. 
Fresh platelet-rich (PRP) and platelet-poor plasmas (PPP) were prepared 
by collecting blood from male rabbits (New Zealand White, 2.5 kg) via 
catheterized femoral artery exsanguination into plastic syringes containing 
3.8% sodium citrate solution (final dilution 1 : 9). Blood was carefully trans- 
ferred to Falcon tubes, centrifuged at 200g for 10 min at 4°C and the PRP 
supernatant collected. The pellets were further centrifuged at 15009 for 20 min 
at 4°C) and PPP supernatant was mixed with the PRP to give a PRP with a 
final platelet concentration of 3 X 105/pL. After mixing, platelets were equi- 
librated at room temperature for 60 min and used within 4 h. 
Antithrombin I11 (ATIII), S-2222, and Factor Xa (KabiVitrum, Molandal, 
Sweden) were reconstituted from lyophilized vials with sterile water per 
supplier’s instructions (Helena Labs, Beaumont, TX) and stored frozen. 
Glass beads (mean diameter 230 pm, Ferro Corp., Cataphote Division, 
Jackson, MS), glass coverslips (Corning, 24 mm x 50 mm) and test tubes 
(3.5 mL volume) were cleaned by soaking in chromic acid for 24 h, washing 
alternately with ethanol and distilled water over 8 h, and drying under vac- 
uum at 50°C. 
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Surface characterization 
Wilhelmy plate contact angle 
Clean glass coverslips were coated with RTV PDMS (1% w/v in tetrahy- 
drofuran (THF)), cured at 50°C in vacuum, soaked in water for 12 h, and 
then redried in vacuum. Plates were then coated in triplicate with PDMS- 
PEO and PDMS-PEO-heparin (2% w/v in THF) and vacuum dried at 40°C. 
Following repeated water-soaking to remove leachables, plates were vac- 
uum dried and analyzed for advancing and receding contact angles on a 
Wilhelmy balance (Wettech, Biomaterials International, Salt Lake City, UT) 
using a double-distilled water medium. Hydrated contact angles were mea- 
sured after l and 12 h continuous immersion in double-distilled water. 
Transmission electron microscopy (TEM) 
Carbon-sputtered copper grids were coated with thin films of PDMS- 
PEO-heparin (0.5% w/v in THF : H,O) and air-dried overnight. Following 
vacuum drying at 22°C grids were exposed to the vapor of RuO, (1% aque- 
ous solution source) for 4 h at room temperature and immediately vacuum 
dried. Transmission electron micrographs were taken with a JEOL JEM 200CX 
instrument. 
Attenuated total reflectance infrared spectroscopy (ATRIFTIR) 
Spectra of PDMS-PEO-Hep block copolymers were obtained with a Digi- 
lab FTS 20/80 spectrometer (0.05 cm-' resolution, 1024 scans, MCT detector). 
Samples were prepared by ambiently casting films of commercial heparin 
(from distilled water), PEO (from THF), PDMS (from THF), PDMS-PEO 
(from THF), and PDMS-PEO-Hep (from THF :water) onto zinc selenide (ZnSe) 
and germanium (Ge) internal reflection elements (45" facecut angle) and 
vacuum desiccated at room temperature. The uncoated (reference) and 
coated internal reflection elements were aligned at 60" in a Harrick 4X-beam 
condensing variable angle ATR cell and then analyzed. These same films 
were then completely immersed in freshly distilled water for various time 
and reanalyzed in varying states of hydration by ATIUFTIR. The hydrated 
spectra were compared to nonhydrated spectra following baseline flatten- 
ing and absorbance subtraction of pure water spectra from the hydrated 
spectra. 
In vitvo analysis 
Batches of cleaned glass beads and glass test tubes were coated with solu- 
tions (1% w/v in THF or THF/water filtered through Teflon filters, pore size 
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0.5 pm) of RTV PDMS, PDMS-PEO-Hep block copolymers, and the unhepa- 
rinized PDMS-PEO analogues. PEO-coated beads were prepared by using a 
triisocyanate (Colonate L, Nippon Polyurethane Industrial Ltd. , Tokyo, 
Japan) as a cross-linking agent (end group ratio 1 : 1) in 2% w/v solutions of 
PEO in dimethylformamide (DMF). Curing at 60°C in vacuo produced a 
cross-linked, continuous film of "PEO" (a cross-linked PEO-based polyether- 
urethane) insoluble in water. Other coated beads and tubes were suction fil- 
tered, dried at 40°C under vacuum, and then soaked and rinsed four times 
with distilled water to remove unbound heparin and unreacted PEO from 
the copolymer matrix, or acetic acid generated from PDMS cross-linking. 
APTT assays were performed on the final rinse water to confirm that all sol- 
uble heparin had been removed. Half of the PDMS-coated tubes were then 
coated again with PDMS-PEO-heparin and PDMS-PEO copolymers and 
then subjected to the same rinsing and drying treatments. The beads were 
finally mechanically sieved (U. S. Standard #40) to remove aggregates. 
Quantitation of surface-immobilized heparin on coated substrates 
Xecalcification times 
PDMS coatings formed homogeneous cross-linked films after 24 h vac- 
uum curing. Coatings of all polymers on glass tubes were clear, intact, and 
continuous except for slight clouding of the PDMS substrates. 
Glass- and PDMS-coated tubes were used as negative and positive con- 
trols, respectively, in recalcification determinations. The procedure involved 
incubation of 0.5 mL citrated fresh-frozen human plasma and 0.1 mL of a 
saline solution of cephalin in the tubes at 37°C for 1 min followed by the ad- 
dition of 0.05 mL of 0.2 M CaCl,. The plasma solution was monitored for 
clotting by manually dipping a stainless-steel wire hook into the solution to 
detect fibrin threads. Clotting times were recorded at the first signs of fibrin 
formation on the hook. Complete clots typically followed within a minute 
after fibrin was first detected. Cephalin, a phospholipid, was used in the 
assay to supplement plasma phospholipids required in the intrinsically acti- 
vated coagulation pathway. Excess amounts of phospholipids served to ac- 
celerate fibrin formation and enhance the clotting endpoint once the 
coagulation cascade was activated by exposure to a foreign surface. This im- 
proved endpoint detection and reproducibility of the assay. 
Toluidine blue assay 
Surface-immobilized heparin was quantified by the procedure of Smith 
and coworkers'* with slight modifications to accommodate coated beads. 
Seven tubes, each containing 2.0 mL of the toluidine blue solution and 
0.01 mL of the various heparin standard solutions (4 to 14 pg/mL in 0.2% 
NaCl), were vortexed for 30 s. Blanks utilizing 0.01 mL 0.2% NaCl instead 
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of the heparin solutions were made analogously. Bead blanks were ob- 
tained by vortexing 100 mg of clean glass beads in 2 mL of the toluidine 
blue solution for 30 s. Copolymer-coated beads in quantities of 50-300 mg 
were also vortexed with 2 mL toluidine blue for 30 s. Both bead systems, 
heparin standards, and blanks were then vortexed with 5 mL hexane to 
adsorb dye-bound heparin not immobilized on the coated surfaces to the 
hexane:water interface. The aqueous layers were finally monitored for UV 
absorbance at 631 nm (Perkin-Elmer Lambda W/Vis  7 spectrophotometer) 
within 15 min. 
Thrombin times 
Inhibition of thrombin generation by heparinized surfaces was compared 
to heparin standards by the procedure of Sirridge and Shannon" modified 
to monitor coated beads. Beads coated with cross-linked PDMS, PDMS- 
PEO-Hep block copolymers and PDMS-PEO unheparinized copolymer 
analogs (20-50 mg) were weighed into Fibrosystem Fibrocups and incu- 
bated for 10 min at 37°C with PPP (0.1 mL). Thrombin (0.1 mL, 10 U/mL) 
was added and clotting times measured on a Fibrosystem Fibrometer. These 
results were compared to results from heparinized plasma standards (0.05- 
0.25 U/mL). 
Factor Xa assay 
Surface-immobilized heparin was analyzed for bioactivity by a chromo- 
genic assay by the method of Tein and co~orkers '~ , '~  modified to evaluate 
coated beads. Heparin standards in Tris buffer (pH 8.4, 25°C) were made in 
a range of 0.1-0.6 U/mL. A 6-point standard curve was constructed by av- 
eraging the results of five samples of each concentration evaluated by the 
following procedure: 
Heparin standards (0.1 mL) were diluted in Falcon tubes with 0.1 mL 
ATIII and 0.8 mL buffer. Aliquots of this solution (0.2 mL) were incubated 
at 37°C for 3 min and Factor Xa (0.1 mL, room temperature) was added and 
incubated an additional 30 s. S-2222 (0.1 mL, 2 mM, 37°C) was then added 
and incubated at 37°C for 3 min. The reaction was then terminated by 
adding 0.3 mL of 20% acetic acid and mixing. Samples were monitored 
spectrophotometrically at 405 nm using a Perkin-Elmer Lambda UV/Vis 7 
spectrophotometer against water blanks. 
Coated bead samples of cross-linked PDMS, unheparinized PDMS- 
PEO, and PDMS-PEO-Heparin copolymers were assayed by the following 
procedure: 
Various amounts of each type of bead (5, 10, and 20 mg) were weighed 
into Falcon tubes in sets of six. Each sample was then incubated for 3 min 
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with 0.2 mL AT111 and 0.18 mL buffer at 37°C with occasional shaking to 
promote wetting. Factor Xa, S-2222, and acetic acid were then added over 
the same time course and in identical quantities as for the heparin stan- 
dards. Aliquots were monitored for absorbance at 405 nm and compared to 
the heparin standard curve. 
Platelet adhesion 
Quantities of coated beads (700 mg) were carefully weighed into plastic 
disposable 3-cm3 syringes and equilibrated with 2 mL PBS buffer (pH = 
7.4) overnight prior to platelet adhesion studies. Buffer was squeezed out 
and 0.5 mL PRP introduced via another syringe. The syringes were tapped 
to remove air bubbles. They were then sealed with parafilm and rotated 
through a water bath at 37°C so that the beads were constantly falling 
through the PRP. Sets of syringes were arranged for adhesion time intervals 
of 15,30,45, and 60 min of PRP incubation. At each time point, the syringes 
were quickly removed from the rotating bath, emptied into Falcon tubes 
and counted immediately with the Coulter Counter. A control sample of 
PRP incubated without beads was used as a reference for each time point. 
After depletion measurements, the beads were immersed in an isoosmotic 
fixative containing glutaraldehyde and parafomaldehyde in buffer for 12 h. 
Following rinsing with distilled water, the beads were then freeze-dried and 
observed under scanning electron microscopy (JEOL JSM 35). 
C-Serotonin Release 14 
14C-labeled 5-hydroxytryptamine (14C-5HT) was obtained from Amersham 
(0.1 pCi, M) and loaded into platelets in PRP by incubation at 37°C for 
30 min according to a published mefh~d. ’~”~ Aliquots of PRP were aggre- 
gated with ADP, thrombin, and collagen to represent 100% release. Un- 
treated PRP represented background or 0% release. Platelets centrifuged at 
l500g for 10 min demonstrated little additional release above background. 
The same procedure used for platelet adhesion experiments was used for 
5-HT release analysis with slight modifications. Only 15- and 30-min incu- 
bation periods were utilized. The syringe contents were emptied after these 
incubations into Falcon tubes in an ice-bath. PRP samples (0.05 mL) were 
removed and the tubes quickly centrifuged at 1500g for 5 min at 4°C to in- 
hibit l4C-5HT re-uptake. Aliquots (0.01 mL) of the resulting PPP superna- 
tant showed no platelet populations and were counted together with the 
PRP samples in a Beckman scintillation counter to quantify 14C-5HT release. 
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Surface characterization 
Results for Wilhelmy Plate contact angle measurement on films of PDMS, 
PDMS-PEO and PDMS-PEO-Hep are shown in Table I. One striking result 
of the hysteresis comparisons is that, after the initial immersion in water, 
the heparinized copolymer advancing and receding contact angles differ by 
only lo", displaying very little hysteresis compared to both PDMS and 
PDMS-PEO. Another interesting result is that, in all cases, extended hydra- 
tion does not seem to affect advancing and receding angles, or hysteresis 
significantly after the initial wetting. One possible explanation is that, after 
immersion, water penetrates readily into PDMS-PEO and PDMS-PEO-Hep 
films (on the order of minutes) so that dry films quickly attain a hydrated 
state during Wilhelmy immersion. 
The initial immersions (first advancing angle) for both PDMS-PEO and 
PDMS-PEO-Hep exhibit advancing angles nearly equal to that of pure 
PDMS, indicating that these surfaces in the dry state are very hydrophobic 
and probably rich in PDMS. These copolymer surfaces reorient rapidly under 
water during the first immersion so that the subsequent receding angles 
(first emersion) are substantially lower than PDMS (more hydrophilic). In 
addition, the subsequent advancing angles are dramatically reduced for 
PDMS-PEO and PDMS-PEO-Hep. One explanation for these nearly instan- 
taneous reduced advancing angles in the amphiphilic block copolymers is 
that PDMS, originally exposed at the surface, buries itself under PEO do- 
mains upon exposure to water. This PDMS-rich overlayer reorients to mini- 
TABLE I 
Wilhelmy Plate Contact Angle Data for PDMS-PEO-Heparin in Water 
Hydration Time 
Substrate' (h) Adv. Angle Rec. Angle Hysteresis 
PDMS 0 108.7 ? 5.3 79.5 f 1.6 29 
1 103.5 f 2.6 72.0 -C 1.5 30 
12 103.6 f 3.7 71.4 t 1.1 32 
PDMS-I'EO Ob 100.0 f 4.5 53.6 t 1.1 46 
0' 86.8 2 1.2 53.6 2 1.1 33 
1 88.7 f 2.1 49.9 f 4.4 40 
12 88.7 * 1.9 53.5 f 1.4 35 
PDMS-PEO-Hep Ob 109.8 f 2.4 45.8 f 1.8 64 
0' 56.2 f 1.2 45.8 f 1.8 10 
1 58.1 f 11.8 48.5 t 1.5 10 
12 58.7 _C 1.9 48.9 f 2.1 10 
"n = 3, f S.D. 
bFirst advancing angle. 
'Subsequent advancing angles. 
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mize interfacial tension by burying hydrophobic PDMS regions from the 
interface in order to expose hydrophilic PEO and heparin. In addition, the 
changes in advancing angles may reflect the time dependence of the Wil- 
helmy procedure (rate of film immersion and emersion). 
PDMS-PEO may act as a surfactant analogue during wetting, forming a 
stable solid state quasimicellar structure with the PDMS blocks oriented to- 
ward the hydrophobic interior and water-saturated PEO covering the exterior 
in a swollen state in order to minimize interfacial energy. In PDMS-PEO-Hep, 
both PEO and heparin could act to stabilize PDMS in such a quasi-micellar 
state. In addition, PEO and heparin could reorganize on the water-swollen 
gel-like surface to limit the mobility of PDMS. All of these effects may act in 
unison within the block copolymers to reduce the advancing contact angles, 
prevent PDMS from resurfacing in air by restricting its mobility, and thus, 
demonstrate reduced hysteresis, particularly in the case of PDMS-PEO-Hep. 
Previous swelling data6 suggest that these copolymers contain substantial 
amounts of water which would cause PDMS to require a stable position 
away from the penetrating water. A relatively hydrophobic region inside 
domains of PEO and heparin is feasible from a thermodynamic perspective 
and physically possible as shown by DSC data.17 The Si-0 bonds in PDMS 
and the C-0 bonds in PEO and heparin are all very mobile, flexible link- 
ages imparting the unique physical characteristics and structural rearrange- 
ments observed for these molecules. This permits hydrophobic PDMS to 
reorient during immersion and emersion, manifested as hysteresis. Time- 
dependent changes upon hydration are minimal due to minimal water up- 
take by these PDMS films. Advancing angles for PDMS indicate its high 
hydrophobicity, as expected, at all hydration times. 
suggesting some degree of 
reorientation to minimize interfacial energetics with water. PDMS-PEO dis- 
plays a larger hysteresis value at all degrees of hydration, suggesting greater 
interaction with water due to its hydrophilic component, possibly in the 
forms of swelling and water penetration throughout the matrix. Receding 
angles, indicative of the hydrophilic portion of a surface, demonstrate as 
anticipated that PDMS-PEO-Hep has greater hydrophilicity than either 
PDMS or PDMS-PEO. In addition, its low hysteresis suggests that water 
penetrates rapidly into the hydrophilic PDMS-PEO-Hep surface, creating 
a swollen gel-like matrix where PDMS may bury away from the surface. 
Even upon emersion, this structure may be sufficiently stabilized by the 
fully hydrated copolymer matrix to prevent PDMS from resurfacing in an 
air environment. 
Figure 2 shows a transmission electron micrograph of PDMS-PEO-Hep 
stained with RuO, vapor. Domains stained very dark are thought to be sur- 
face structures of PEO or heparin since ether linkages are oxidized rapidly 
by RuO,.” Also, the differences in electron density between PDMS and the 
other blocks provide an inherent phase contrast thought to be manifested 
as light gra regions of PDMS. Domains are scattered regions approxi- 
mately 100 1 in diameter (or length) interconnected by bridges of the same 
Hysteresis for this substrate is rather 
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Figure 2. 
films. 
Transmission electron micrograph of PDMS-PEO-heparin thin 
segment. This surface is representative of that cast into a hydrophobic air 
environment, and thus would be expected to demonstrate a surface enrich- 
ment of PDMS to minimize interfacial energy. 
ATWTIR spectra of desiccated PDMS-PEO-Hep and control surfaces are 
illustrated in Figures 3 through 7. The refractive index of the zinc selenide 
(ZnSe) crystal was 2.42 and that of the germanium (Ge) crystal was 4.0. The 
critical incident angles for the internal reflection elements with 45" facecut 
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Figure 3. FTIIUATR spectra for PDMS: (A) Ge internal reflection element 
(0-1.5 absorbance), (B) ZnSe internal reflection elemer (0.0-8.0 absorbance). 
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Figure 4. FTIWATR spectra for PEO: (A) Ge internal reflection element (0- 
2.0 absorbance), (B) ZnSe internal reflection element (0.0-1.3 absorbance). 
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Figure 5. FTIWATR spectra for heparin: (A) Ge internal reflection element 
(0-1.6 absorbance), (B) ZnSe internal reflection element (0.0-0.2 absorbance). 
Wavenumbers 
Figure 6. FTIR/ATR spectra for PDMS-PEO: (A) Ge internal reflection 
element (0-0.9 absorbance), (B) ZnSe internal reflection element (0.0-2.6 
absorbance). 
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Figure 7. FTIWATR spectra for PDMS-PEO-heparin: (A) Ge internal reflec- 
tion element (0-0.8 absorbance), (B) ZnSe internal reflection element (0.0- 
8.0 absorbance). 
angles and aligned at 60" are 48.7" and 51.1" for Ge and ZnSe, respectively.'" 
The calculated sampling depths into the polymer surfaces are 1000 to 
3000 A and 2000 to 8000 A from 4000 to 900 cm-' when cast onto the Ge and 
ZnSe elements, respectively. 
Figure 3 illustrates PDMS spectra for PDMS films cast onto the Ge inter- 
nal reflection element (spectrum A) and ZnSe (spectrum B), respectively. 
Table I1 lists the vibrational modes associated with the major bands. The 
characteristic PDMS bands include Si- CH, symmetric deformation at 
1259 cm-' and Si-0 stretching near 1085 and 1014 cm-'. 
PEO spectra of films cast onto Ge and ZnSe are illustrated in Figures 4A 
and 4B, respectively. Vibrational modes assigned to major bands in the 
spectra are given in Table 111. Characteristic bands of the polyether include 
the 1115-~n-~ C - 0 - C asymmetric stretching and the 1076-cm-' C - 0 - C 
symmetric stretching . 
Heparin films on Ge and ZnSe are shown in Figure 5A and 5B, respec- 
tively. The band assignments are listed in Table IV. Heparin spectra include 
characteristic bands at 3287 cm-' from overlapping 0-H and N-H vibra- 
tions, 1735-cm-' C = 0 stretching, 1617-cm-l carboxylate C = 0 stretching, 
1146-cm-' cyclic ether (sugar ring) stretching and possibly S=O stretching, 
and several lower wavenumber bands associated with COOC and OS= 0 
vibrations. 
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TABLE I1 
Poly(dimethylsi1oxane) Band Assignments 
Wavenumber (a-') Vibrational Mode 
2963 CH3 C-H asymmetric stretching 
2906 
1415 C - H bending 
1259 Si- CH3 symmetric stretching 
1085 Si - 0 stretching 
1014 Si- 0 stretching 
CH3 C- H symmetric stretching 
PDMS-PEO diblock copolymer spectra are shown in Figure 6 on Ge (A) 
and ZnSe (B), while vibrational modes of characteristic bands are given in 
Table V. Absorbance ratios of spectral bands characteristic of individual 
blocks suggest enrichment of PDMS or PEO phases as a function of sam- 
pling depth. PDMS-PEO (Ge) spectra include 0-H stretching (3316 cm-') 
TABLE I11 
Polyethylene Oxide Band Assignments 
Wavenumber (m-') Vibrational Mode 
~~~ ~ 
3344 
2886 
1473 
1356-1350 
1115 
1076 
949 
0-H stretching 
CHI C-H symmetric stretching 
C-Hbending 
CH2-0 stretching, C-H deformations 
C-0-C asymmetric stretching 
C- 0- C symmetric stretching 
C-H deformations 
TABLE IV 
Heparin Band Assignments 
Wavenumber (cm-') Vibrational Mode 
3287 
2967 
2922 
2852 
1735 
1617 
1539 
1460-1428 
1415 
1260-1200 
1150-1100 
1018 
0-H, N-H stretching 
CH, C-H asymmetric stretching 
CH, C-H asymmetric stretching 
CH2 C-H symmetric stretching 
COO C= 0 stretching 
COO- asymmetric stretching 
N-H bending, C-N stretching 
C-H deformations, S=O stretching 
COO- carboxylate symmetric stretching 
COOC asymmetric stretching 
C-N stretching, N-H bending 
S= 0 asymmetric stretching 
COOC symmetric stretching 
C-0-C cyclic ether, S=O stretching 
C-0  symmetric stretching 
SO0 stretching 
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TABLE V 
PDMS-PEO Block Copolymer Band Assignments 
Wavenumber (cm-') Vibrational Mode 
3316 N-H, 0 -H  stretching 
2964 CH, C-H asymmetric stretching 
2884 CH, C-H symmetric stretching 
1680 
1548 N-H bending, C-N stretching 
1472-1430 C-H deformations 
1345 OCH2 stretching 
1263 Si- CH, symmetric deformation 
1101 COC asymmetric stretching 
1065 COC symmetric stretching 
1026 Si-0 stretching 
C= 0 stretching urea Amide I 
urea Amide II 
960 C-H deformations 
TABLE VI 
PDMS-PEO-Hep Band Assignments 
Wavenumbers (cm-') Vibrational Mode 
3295 N-H, 0-H stretching 
2961 CH, C-H asymmetric stretching 
2887 CH2 C-H symmetric stretching 
1740 COO- C= 0 stretching 
1672 
1601 COO- C= 0 stretching 
1545 N-H bending, C-N stretching 
1460-1430 C-H deformations 
1415 COO- symmetric stretching 
1343 OCH, stretching 
1261 CH3- Si deformation 
1250-1150 COOC stretching 
C-N stretching, N-H bending 
1189 S=O stretching 
1106 C-0-C asymmetric stretching 
1072 C-0-C symmetric stretching 
C = 0 stretching urea Amide I 
urea Amide II 
1307 s=o stretching 
S=O stretching 
and C-0-C stretching (1101 cm-') bands characteristic of PEO, as well 
as the Si-CH, symmetric deformation (1263 cm-') and Si-0 stretching 
bands (1026 cm-') characteristic of PDMS. Coupling of the semitelechelic 
amino-PDMS via a diisocyanate to the diamino terminated PEO is con- 
firmed by the urethane and urea linkages resulting in the weak band near 
1680 cm-' (C=O stretching; urea Amide I) and the 1548-cm-' band (C-N 
stretching and N-H bending; Amide 11). 
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Absorbance ratios of the intense PEO C-0-C stretching band at 
1101 cm-' to the PDMS Si-CH, stretching band at 1263 cm-I or to the 
PDMS Si-0 band at 1026 cm-' are greater for the Ge spectra (1.94 or 1.28 
ratios) than for the ZnSe spectra (1.88 or 0.91 ratios). This suggests an en- 
richment of PEO within the near-surface sampling depths (1000-3000 A) as 
compared to the greater sampling depths (2000-8000 A). This is a different 
trend than observed with angle-dependent ESCA (ADESCA) and contact 
angle results." The difference ma be explained by the near-surface sam- 
depths (approximately 100 A) of ADESCA and contact angles. 
Desiccated PDMS-PEO-Hep spectra are illustrated in Figure 7 and band 
assignments listed in Table VI. Both spectra exhibit the salient features of 
PEO, PDMS, and heparin constituents. Dominant aliphatic C-0-C 
asymmetric stretching vibrations at 1106 cm-l indicate PEOs presence. The 
COO- C = 0 stretching band at 1415 cm-I is characteristic of heparin. Broad 
weak bands absorbing between 1255-1150 cm-' and 1020 cm-' are sugges- 
pling depths (greater than 1000 A' ) as compared to the surface sampling 
TABLE VII 
Recalcification Times for PDMS-PEO-Heparin 
Clot Time 
Substrate PDMS M.W. PEO M. W. Heparin Method (s)' 
Polymers on Glass 
Glass 
PDMS-PEO1 
PDMS-PE02 
PDMS-PEO1-Hep 
PDMS-PEOI-Hep 
Polymers on PDMS 
PDMS 
PDMS-PEO1 
PDMS-PEO2 
PDMS-PEO1-Hep 
PDMS-PEO1-Hep 
- 
9500 
9500 
9500 
9500 
Cross-linked 
9500 
9500 
9500 
9500 
- 
4000 
6000 
4000 
4000 
- 
4000 
6000 
4000 
4000 
- 
- 
EDC 
NaCNBH, 
- 
- 
- 
EDC 
NaCNBH, 
149 f 11 
461 2 45 
676 f 46 
772 k 68 
744 f 79 
586 t 25 
585 -+ 46 
612 * 56 
703 2 62 
744 * 79 
an = 8. ? S.D. 
TABLE VIII 
In Vitro Quantitation of Surface-Immobilized Heparin 
Heparin Surface Concentration 
Method" 
Substrate Tol. Blue (g/cm*) Thrombin (U/cm') Factor Xa (U/cm2) 
~- 
PDMS 0 0 0 
PDMS-PEO-Heparin 0.55 2.65 X 2.66 x lo-' 
PDMS-PEO 0 0 2.65 x 
aAverage of 6 samples, assuming bead diameter of 230 m and bead density of 
2.5 g/cm3. 
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tive of heparin and PDMS. The weak urea Amide I vibrations confirm the 
coupling between the PDMS and PEO. 
Ratios of characteristic constituent bands within each spectrum demon- 
strate different segmental compositions for each sampling depth. For ex- 
ample, ratios of heparin's carboxylate band at 1601 cm-' versus PDMS 
Si-CH, band at 1261 cm-' suggest nearly twice the concentration of hepa- 
rin (or half the amount of PDMS) present at the ZnSe sampling depth (0.51 
ratio) than for the Ge sampling depth (0.17 ratio). Similar comparisons con- 
firm increased PEO within the ZnSe sampling depth as compared to that of 
Ge. Therefore, the data suggest PDMS enrichment within the near-surface 
regions of the heterogeneous copolymers that are probed with Ge internal 
reflection elements, as well as an enrichment of PEO and heparin within 
the deeper sampling depths probed with the ZnSe internal reflection ele- 
ments. This concurs with the data obtained using the more surface-sensi- 
tive ADESCA te~hnique.'~ 
Hydrated films of PDMS-PEO-Hep demonstrate that reorganization 
occurs within the sampling depths as compared to the desiccated spectra as 
a function of hydration time. Samples hydrated for 10 min were analyzed in 
a hydrated state following water subtraction as shown in Figures 8A and 
8B. The PDMS-PEO-Hep spectrum within the near-surface sampling depths 
(Fig. 8A) has a more intense 0-H stretching band at 3420 cm-' suggesting 
residual from water subtraction. A shoulder at 3207 cm-', possibly associ- 
ated with N-H stretching or a carboxyl stretching overtone (both from 
heparin), increases with Ionger hydration times, suggesting increasing hepa- 
rin concentrations within this sampling depth. Intensities of CH, C-H 
stretching vibrations absorbing 2887 cm-' decrease with increasing hydra- 
tion times. The bands absorbing near 1350 cm-' with a high wavenumber 
shoulder are also characteristic of PEO and have been assigned to 0-CH, 
stretching vibrations. The high wavenumber shoulder decreases with in- 
creasing hydration times. Hydrated PDMS-PEO-Hep spectra obtained at 
greater sampling depths (Fig. 8B) are similar to the near-surface spectra. 
However, the 1361-cm-' and 1279-cm-' shoulders associated with 0 - CH, 
stretching and Si- CH, symmetric deformations change significantly with 
increasing hydration. 
Figures 9A and 9B show PDMS-PEO-Hep spectra hydrated for 18 h after 
water substraction obtained with the Ge and ZnSe internal reflection ele- 
ments, respectively. The near-surface spectrum (Fig. 9A) indicates the 
PDMS-PEO-Hep film experienced reorientation with hydration. First, the 
intensity of the N-H stretching band (3207 cm-') has increased dramati- 
cally, suggesting structural relaxations allowing alterations in hydrogen 
bonding or concentrations of heparin and urea linkages within the sam- 
pling depth. In addition, intensities of the PDMS methyl C-H stretching 
bands absorbing near 2960 cm-' have decreased, indicating a decrease of 
PDMS. An additional weak band is evident near 2364 cm-' that may be as- 
sociated with increased amounts protonated secondary and tertiary amines 
on heparin (NH,', NH' stretching) as hydration occurs further within the 
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Figure 8. FTIR/ATR spectra for PDMS-PEO-heparin hydrated 10 min: 
(A) Ge internal reflection element (0-5.0 absorbance), (B) ZnSe internal re- 
flection element (0.0-5.0 absorbance). 
polymer. Bands characteristic of PDMS absorbing at 1263 cm-', 1097 cm-', 
and 1024 cm-I have decreased significantly in intensity. PEO and heparin 
associated bands near 1206 cm-' and 1154 cm-' have increased intensities. 
Wavenumbers 
Figure 9. FTIWATR spectra for PDMS-PEO-heparin hydrated 18 h: (A) Ge 
internal reflection element (0-5.0 absorbance), (B) ZnSe internal reflection 
element (0.0-5.0 absorbance). 
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These observations support the hypothesis of near-surface restructuring 
with hydration, allowing increasing concentrations of hydrophilic segments 
near the surface. The ZnSe spectra (Fig. 9B) obtained following 18 h hydra- 
tion demonstrate similar trends suggesting that hydration occurs within 
both sampling depths and results in similar restructuring at both depths. 
In vitvo studies 
In all bioactivity studies, except recalcification times, only PDMS-PEO- 
Hep copolymers prepared by NaCNBH, were used. Heparinized copoly- 
mers prepared by both EDC and NaCNBH, methods show prolonged 
clotting times over their unheparinized analogues and the PDMS control 
surfaces as tested by recalcification times. Table VII lists respective clotting 
times for the polymer coatings on both glass and PDMS substrates. These 
data demonstrate extended clotting times for all polymers as compared to 
glass with the greatest prolongation caused by the heparinized substrates 
( p  < 0.001 for PDMS-PEO-Hep on glass compared to PDMS-PEO(4000) on 
glass). Extended clotting times of cross-linked PDMS alone are consistent 
with findings of other researchers.21,22 No significant differences exist be- 
tween the heparinized coatings on glass as compared to the heparinized 
coatings on PDMS. However, the heparinized coatings on PDMS exhibit 
significantly longer clotting times than their unheparinized analog on 
PDMS ( p  < 0.01 for EDC-prepared heparinized copolymers versus PDMS- 
PEO(4000) and p < 0.001 for NaCNBH,-prepared heparinized copolymers 
versus PDMS-PEO(4000) on PDMS). In addition, artifacts may be partially 
induced by the coating procedure. Clear, bare glass surfaces may promote 
hydrophilic PEO and heparin blocks to coat preferentially onto hydrophilic 
glass, while PDMS substrates promote PDMS blocks to adhere. Thus, the 
other respective blocks may be forced to face out toward the air interface 
while curing, and subsequently face the plasma interface during bioassays. 
Because the bioactive effects of heparin were not as convincing as antici- 
pated, other bioactivity assays were undertaken to attempt to distinguish 
heparinized and nonheparinized coating performance. 
A linear relationship (r2 = 0.960) exists between the UV absorbance at 
631 nm and the amounts of heparinized block copolymer-coated beads in 
the toluidine blue determinations. Blanks containing beads compared well 
with blanks containing only 0.2% NaCl, demonstrating that nonspecific 
dye-binding was minimal. Calculation of coated bead dye-binding corre- 
lated to the heparin standard curve indicates that the surface-immobilized 
heparin content of the coated beads was 41.5 (k14.8) pg heparin per gram 
of beads or, assuming i? bead diameter of 230 pm and a reported glass bead 
density of 2.5 g/cm3, 0.55 pg/cm2 surface concentration. 
In thrombin time measurements, 50 mg of unheparinized PDMS- and 
PDMS-PEO-coated beads showed no prolongation of clotting times (13 ? 
1.1 s), while 50 mg of heparinized copolymer beads prevented clotting in 
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the Fibrocup in excess of 200 s. Smaller quantities of heparinized beads 
(20 mg) exhibited averaged clotting times of 46.73 (27.3) s. This bioactivity 
corresponded to a heparin concentration of 0.33 U/mL if compared to the 
heparin standard curve. If compared to the actual amounts of heparin 
within each standard (by recalculating the standard curve in terms of 
amounts of heparin instead of concentrations), then 20 mg of heparinized 
copolymer-coated beads represents 0.04 U of heparin or, assuming a total 
20-mg surface area of 1.51 cm’, a heparin surface concentration of 2.65 X 
Factor Xa results correlate well with thrombin time data. The method in- 
volves analyzing heparin as a bioactive complex of heparin and ATIII and 
its ability to bind and neutralize a known amount of Factor Xa. Unbound, 
excess Factor Xa then catalyzes the release of a chromogenic molecule, 
p-nitroanaline (pNA) from a substrate (Bz-Ile-Glu-Gly-Arg-pNA) and the 
amount of pNA detected photometrically is inversely proportional to 
the amount of bioactive heparin present. Unlike the toluidine blue assay 
which detects all heparin able to bind the dye, the Factor Xa assay detects 
only the heparin on the surface which is bioactive, forming complexes with 
both ATIII and Factor Xa. 
In the Factor Xa analysis, the heparin standard curve for the chromogenic 
assay demonstrated reliable linearity (r2 = 0.970). Sample absorbances of 
less than 0.120 were assumed to deviate from this linearity and were dis- 
carded. For this reason, amounts of PDMS-PEO-Hep copolymer-coated 
beads in excess of 5 mg showed heparin bioactivities giving absorbances in 
this range and could not be included in the assay. However, control beads 
coated with PDMS and PDMS-PEO were assayed in amounts up to 20 mg. 
PDMS beads showed absorbance corresponding to baseline levels of blank 
standards for all quantities of beads. PDMS-PEO copolymer beads (20 mg) 
demonstrated absorbances corresponding to 0.004 U of heparin (2.65 x 
U/cm’), indicating some nonspecific absorption of Factor Xa to this 
coating. Smaller quantities of these beads, however, gave absorbances 
equivalent to the blanks. Heparinized block copolymer-coated beads (5 mg) 
resulted in absorbances which when correlated to the standard curve, corre- 
sponded to 0.010 U of heparin or 2.66 x U/cm’, nearly an order of 
magnitude greater than its unheparinized analogue. This measured surface 
concentration of heparin is nearly identical to concentrations determined by 
thrombin times. 
Results of the in vitvo bead bioactivity assays are summarized in Table VIII. 
Given the experimentally determined activity of the heparinized copolymer 
surface (2.66 x U/cm‘) and the original activity of the immobilized 
heparin sodium salt (165.4 U/mg),6 the calculated amount of bioactive im- 
mobilized heparin is 0.16 pglcm’. The toluidine blue assay which measures 
heparin, bioactive or not, indicates nearly 3.5 times this amount on the sur- 
face, implying that only one in three or four surface immobilized heparin 
molecules is bioactive. 
U/cm2. 
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Depletion of platelets from PRP at 37°C was monitored on all polymeric 
coatings over time. Figure 10 shows the percent depletion of platelets from 
PRP at 15-, 30-, 45-, and 60-min intervals. Although previously published 
data for platelet adhesion and blood clottability on PDMS are inconsis- 
cross-linked PEO-based polyether-urethane, PDMS, and PDMS- 
PEO-Hep exhibit very low platelet adhesion compared to Biomer control 
surfaces. In addition, although no quantitative analysis was obtained, 
platelet aggregates in the bulk fluid phase were qualitatively noted from 
Coulter Counter distributions to increase over time for the cross-linked 
PEO-based polyetherurethane and Biomer systems and remain surprisingly 
low in both PDMS and PDMS-PEO-Hep systems. This suggests some 
polyurethane-specific aggregation activating mechanism that may be at- 
tributed to the urethane linkages. 
Platelet adhesion in general appears to be a necessary precursor for sub- 
sequent platelet release and aggregation after surface activation." Release of 
5-HT via activation, however, does not necessarily have to correlate with 
platelet adhesion, as the release reaction does not appear to be an essential 
Platelet Adhesion from Rabbit PRP 
T 
Biorner 
PEO 
PDMS-PEO-HEP 
PDMS 
o ! .  I . ,  . I .  1 .  I ,  1 
10 20 30 40 50 60 70  
l ime  (min.) 
Figure 10. In vitro platelet adhesion to PDMS-PEO-heparin (PDMS M ,  = 
9500, PEO M, = 4000, heparin M, = 10000). 
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prerequisite for platelet adhesion or platelet aggregation. Platelet activa- 
tion as monitored by 5-HT release shown in Figure 11 demonstrates that 
the Biomer surface induces both high adhesion and severe release, while the 
heparinized copolymer and cross-linked homopolymers all demonstrate 
low levels of release, Comparison of data for PDMS-PEO-Hep system and 
controls suggests that there is a close correlation between platelet adhesion 
and release. Thus, it appears as though those platelets that do adhere are 
also those that activate to some extent in contact with the surface, releasing 
serotonin. In corroboration with others,” materials which induce the most 
platelet release and activation (Biomer, cross-linked PEO-based polyether- 
urethane to lesser extent) were qualitatively noted in these studies to produce 
more bulk platelet aggregates (as measured by Coulter Counter counting 
distributions). 
Re-uptake of released serotonin after platelet activation and degranula- 
tion is a legitimate concern. Active uptake suppression by rapid cooling in 
an ice bath is slow, compared to or pharmacological methodsz9 
and may result in quantification errors. However, other researchx compar- 
ing imipramine-treated and untreated platelet release levels demonstrated 
only slight differences. Therefore, we felt justified in using cooling to pre- 
vent reuptake of serotonin. In addition, quantitative mass balances of sero- 
tonin levels inside platelets versus levels in plasma during release reactions 
Serotonin Release from PDMS-PEO-Heparin 
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Figure 11. In vitro ‘‘C-serotonin release from platelets on PDMS-PEO-Hep 
(PDMS M, = 9500, PEO M, = 4000, heparin M, = lO000). 
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have demonstrated a negligible rate of 5-HT reuptake by either adherent or 
bulk platelets after surface a~tivation.~' 
Figures 12A-D show SEM micrographs of platelets attached to the test 
substrates. As expected, the PDMS beads (Fig. 12A) are virtually bare- 
field after field showed no platelets at all. One explanation for these results 
would be that the surface was not wetting. Considering the buffer equili- 
bration period, the ability of plasma proteins to promote wetting in PRI', 
and low levels of 5-HT release detected, the apparent PDMS passivity can- 
not be explained by a nonwetting surface. The PDMS-PEO-Hep-coated 
beads (Fig. 12B) show a few adherent platelets with varying degrees of acti- 
vation. No aggregates are observed. This suggests that, compared to PDMS, 
(a) 
Figure 12. Scanning electron micrographs of adhered platelets (original 
magnifications) (a) PDMS (X400), (b) PDMS-PEO-Hep (x3600), (c) PEO 
(X 1300), (d) Biomer ( x 3600). 
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(b) 
Figure 12. (continued) 
the heparinized system, demonstrating higher degrees of activation and re- 
lease, may be causing some heparin-induced platelet a~tivation.~’ In addi- 
tion, it is interesting to note wrinkles in the underlying polymer film caused 
by SEM sample preparation-swelling in buffer and plasma followed by 
vacuum drying. Such swelling upon hydration presents a mobile, gel-like 
surface with an apparent increase in surface area. Hydrophilic surfaces, 
however, have been shown to decrease platelet adhe~ ion ,~~-~’  and may ac- 
count for low platelet adhesion levels on this substrate. By contrast, the 
cross-linked PEO-based polyether-urethane surface (Fig. 12C) shows higher 
degrees of platelet adhesion, activation, pseudopodia extension, and aggre- 
gation, consistent with adhesion and release quantification. Some platelets 
have completely lost their morphology, indicating complete activation, 
while others are clumped into multiple platelet aggregates. Figure l2D shows 
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(c) 
Figure 12. (continued) 
platelets adhered onto a Biomer-coated bead. In this micrograph, platelets 
are maximally activated (flattened forms) with a possible second overlayer 
adhering on top of them. Pseudopodia and spreading are prevalent and a 
large majority of the surface is covered. This result is also consistent with 
Biomer’s high degree of platelet adhesion and detected 5-HT release. 
CONCLUSIONS 
Surface characterization supports the ability of this block copolymer to 
change from ambient air to aqueous environments to present bioactive moi- 
eties toward plasma and also provides a fairly detailed picture of block co- 
polymer chemistry and structure. Contact angle analysis suggests that these 
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(d) 
Figure 12. (continued) 
surfaces are mobile and that the surface chemistry and structure-both in 
vacuum and in aqueous conditions -are different from the bulk chemistry 
and structure. 
ATWFTIR data confirm the presence of all three blocks (PEO, PDMS, and 
heparin) in the PDMS-PEO-Hep triblock copolymer at the two sampling 
depths in both desiccated and hydrated states. More importantly, this data, 
obtained at much deeper sampling depths than contact angle analysis, indi- 
cates segmental enrichment of PDMS in the near-surface regions and dra- 
matic enrichment of PEO and heparin in the deeper regions when films are 
cast under air and desiccated. Heparin and PEO are present in the near- 
surface regions, confirming the concept of PDMS phase enrichment but not 
a pure PDMS overlayer. With hydration, regions sampled by ATR demon- 
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strate dramatic changes in structure and/or segment concentrations. The 
hydrophilic PEO and heparin segments enrich the near-surface areas. 
Relaxation and reorientation occurs under aqueous conditions. Thus, 
the surfaces analyzed under low-energy air environments are probably 
not the surfaces that the platelets and blood proteins sense in an aqueous or 
blood medium. These differences are due to the amphiphilic nature of PDMS- 
PEO-Hep copolymers thermodynamically driven to reorient under chang- 
ing external Conditions. Surface enrichment by the low-energy PDMS 
phases in air is probably reversed under water to expose PEO and heparin 
to aqueous and blood environments, stabilizing PDMS within the interior of 
intra-molecular quasi-micelle structures. 
In nitro comparisons of PDMS-PEO-Hep copolymers with unheparinized 
analogues demonstrate a significant ability of the heparinized coating to 
neutralize clotting factors and prolong clotting times. Comparison of bioac- 
tivity data with direct quantitation of surface-immobilized heparin in the 
polymer indicates that although significant amounts of heparin are detected 
at the surface, only a fraction of these molecules are able to complex both 
ATIII and Factor Xa. It is likely that the coating technique traps or buries parts 
of many heparin molecules within the coating matrix, allowing more heparin 
to be detected than is actually bioactive. Platelet adhesion and release data 
suggest that PDMS-PEO-Hep and its homopolymer constituents react mini- 
mally with platelets in the test systems and seem to pacify surface activation 
compared to Biomer. This observation, combined with the effect of immobi- 
lized heparin on the surface to inactivate key coagulation factors, demon- 
strates the promise of this strategy for surface modification of existing 
hydrophobic biomaterial substrates or as a cross-linkable substrate itself. 
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